Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: An experimental animal model to study atopic dermatitis

Journal of Investigative Dermatology

Volumn 117, Issue 4, 2001, Pages 977-983

  Chan, Lawrence S ^a,b   Robinson, Neha ^b   Xu, Luting ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Eosinophil; IgE; Mast cell; Staphylococcus; T cell

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 4;

ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CLINICAL FEATURE; CONJUNCTIVITIS; CONTROLLED STUDY; EOSINOPHIL; EPIDERMIS; HELPER CELL; HISTOPATHOLOGY; IMMUNOGLOBULIN BLOOD LEVEL; MAST CELL; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PRURITUS; SKIN INFLAMMATION; STAPHYLOCOCCUS INFECTION; TRANSGENIC MOUSE; XEROSIS;

EID: 0034783801     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0022-202X.2001.01484.x     Document Type: Article

References (29)

1. Transfer of allergen-specific IgE-mediated hypersensitivity with allogeneic bone marrow transplantation
2. Atopic dermatitis: Economic evaluation of treatments for eczema and atopic dermatitis
3. Transgenic mice expressing INF-γ in the epidermis have eczema, hair hypopigmentation, and hair loss
4. Abnormal IL-4 gene expression by atopic dermatitis T lymphocytes is reflected in altered nuclear protein interactions with IL-4 transcriptional regulatory element
5. Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune-type disorders in mice
6. Lesional expression of interferon-gamma in atopic eczema
7. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis
8. Diagnostic features of atopic dermatitis
9. Cure of progressive murine Leshmaniasis: Interleukin 4 dominance is abolished by transient CD4+ T cell depletion and T helper cell type 1-selective cytokine therapy
10. Staphylococcal toxins augment specific IgE responses by atopic patients exposed to allergen
11. Linkage and association of an interleukin 4 gene polymorphism with atopic dermatitis in Japanese families
12. Disruption of the murine IL-4 gene blocks Th2 cytokine responses
13. Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulating factor 1 activities and T-cell- and mast-cell-stimulating activities
14. Thymopentin therapy reduces the clinical severity of atopic dermatitis
15. Atopic dermatitis
16. Simultaneous disruption of interleukin (IL)-4 and IL-13 de(r)nes individual roles in T helper cell type 2-mediated responses
17. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice
18. The structure of normal skin and the morphology of atopic eczema
19. Allergen presentation by epidermal Langerhans cells from patients with atopic dermatitis is mediated by IgE
20. IgE in asthma and atopy: Cellular and molecular connections
21. The impact of atopic dermatitis on the quality of life of children, adolescents, and adults
22. Lymphocyte responses and cytokines
23. IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice
24. Interleukin 6: Insights to its function in skin by overexpression in transgenic mice
25. Molecular characterization of an autoallergen, Hom s 1, identified by serum IgE from atopic dermatitis patients
26. Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice
27. Atopic skin disease: A review and a reconsideration of diagnostic criteria
28. Molecular cloning and characterization of a cDNA encoding canine type VII collagen non-collagenous (NC1) domain, the target antigen of autoimmune disease epidermolysis bullosa acquisita (EBA)
29. Defining protective responses to pathogens: Cytokine profiles in leprosy lesions